Browsing: GLP-1 receptor agonists

Weight-loss drugs are facing a bowel cancer question, but the findings are far from settled. We unpack the GLP-1 research, the distinction between polyps and cancer, and what patients should discuss with their doctor.

GLP-1 drugs may do more than suppress appetite. Early trials suggest semaglutide can reduce alcohol cravings and heavy drinking, although it remains an unproven addiction treatment.